Latent class analysis-based subgroups and response to corticosteroids in hospitalised community-acquired pneumonia patients: a validation study
ERJ Open Research, vol. 9, pp. 00577–2022
Abstract
Latent class analysis (LCA), a statistical method to identify ‘hidden’ subgroups within a population, has identified clinically distinct subgroups with treatment implications in acute respiratory distress syndrome and COVID-19 [1–3]. We recently showed that LCA could also identify two clinically distinct subgroups in community-acquired pneumonia (CAP) [4]. In two independent cohorts [5, 6], LCA identified a subgroup with more excessive systemic inflammation and worse prognosis (Class 2), and a subgroup with less systemic inflammation and better prognosis (Class 1). In one of the two cohorts, the Ovidius cohort, we also observed a greater effect of adjunctive dexamethasone on length of stay (LOS) in Class 2 compared to Class 1. The aim of the present study was to validate the existence of LCA defined subgroups in a third, more recent CAP cohort. And if subgroups prove robust, to validate the finding from the Ovidius cohort that subgroups respond differently to adjunctive corticosteroids. Footnotes This manuscript has recently been accepted for publication in the ERJ Open Research . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article. Conflict of interest: Dr. Wittermans has nothing to disclose. Conflict of interest: Dr. van der Zee has nothing to disclose. Conflict of interest: Mr. Qi has nothing to disclose. Conflict of interest: Dr. Grutters has nothing to disclose. Conflict of interest: Dr. Voorn has nothing to disclose. Conflict of interest: Dr. Bos reports grants from Zilveren Kruis Insurance, outside the submitted work. Conflict of interest: Dr. van de Garde has nothing to disclose. Conflict of interest: Dr. Endeman has nothing to disclose.
Authors 8
-
Leiden University · Leiden University Medical Center · St. Antonius Ziekenhuis
Affiliation as printed
Department of Internal Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands
These authors contributed equally
Both authors contributed equally
-
Affiliation as printed
Department of Adult Intensive Care, Erasmus Medical Centre, Rotterdam, The Netherlands
These authors contributed equally
Both authors contributed equally
-
Affiliation as printed
Department of Biostatistics, Erasmus Medical Centre, Rotterdam, The Netherlands
-
Utrecht University · University Medical Center Utrecht · St. Antonius Ziekenhuis
Affiliation as printed
Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
Division of Heart and Lungs, Utrecht University Medical Centre, Utrecht, The Netherlands
-
Affiliation as printed
Department of Medical Microbiology and Immunology, St Antonius Hospital, Nieuwegein, The Netherlands
-
Leiden University · Leiden University Medical Center · St. Antonius Ziekenhuis
Affiliation as printed
Department of Internal Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands
-
Utrecht University · St. Antonius Ziekenhuis
Affiliation as printed
Department of Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands
Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University, Utrecht, The Netherlands
-
Affiliation as printed
Department of Adult Intensive Care, Erasmus Medical Centre, Rotterdam, The Netherlands
Cited by 2 stored of 2
2 results
No patents citing this paper on Lens.org (checked 2026-10-11).
References 13
13 results